Is machine learning the answer for long - acting injectable drugs ?
Scientists in Canada have developed a way of using machine learning to design long-acting injectable drugs, which could slow the development of the advanced drug delivery system, writes the journal Nature Communications in the US. They say they are looking to increase the risk of trial-and-error tests.
Source: europeanpharmaceuticalreview.comPublished on 2023-01-11
Related news
- As data centers proliferate , neighbors knock the noise
- DataStax Accelerates In Asia - Pacific With New Singapore Headquarters
- Christmas dinner will be more expensive this year as inflation rises
- Cost of Christmas dinner for four rises by 3 . 4 % as inflation soars | Harwich and Manningtree Standard
- Chainlink And CF Benchmarks Launch First Market - Wide Interes ...
- Large Hadron Collider Beauty releases first set of data to the public
- Cost of Christmas dinner for four rises by 3 . 4 % as inflation soars
- Judge denies bond for woman accused of killing 15 - year - old girl
- Georgian PM participates in OGP Global Summit
- Cost of Christmas dinner for four rises by 3 . 4 % as inflation soars | Darlington and Stockton Times
- NICE Alliance Announces New Adopters , Toyo Media Links and Headwaters , Which Accelerate the Expansion of Advanced AI based Secure Services of NICE Ecosystem Across Industries – Consumer Electronics Net
- Google Maps to show wildfire locations , emergency contacts
- Boulder Police Using New Data System to Create Strategic Plan
- CERN : Large Hadron Collider Beauty experiment releases first set of data to the public
- InfoSum and REaD Group announce permissioned database partnership